<DOC>
	<DOCNO>NCT02291679</DOCNO>
	<brief_summary>The objective trial determine efficacy safety linaclotide administer patient chronic idiopathic constipation ( CIC ) . The primary efficacy parameter percentage patient dose group meet protocol definition Complete Spontaneous Bowel Movement ( CSBM ) Overall Responder .</brief_summary>
	<brief_title>Trial Linaclotide Patients With Chronic Idiopathic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Patient complete colonoscopy one need accord AGA criterion , clinically significant finding Patient clinically significant finding physical examination clinical laboratory test Patient meet protocol criterion CIC : report &lt; 3 bowel movement per week report one follow â‰¥ 25 % BMs : straining , lumpy hard stool , sensation incomplete evacuation Patient demonstrate continue chronic idiopathic constipation Pretreatment Period Patient compliant daily IVRS ( interactive voice response system ) call Patient history loose watery stool Patient symptom diagnose Irritable Bowel Syndrome ( IBS ) Patient structural abnormality gastrointestinal ( GI ) tract disease condition affect GI motility Patient protocolexcluded clinically significant medical surgical history could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>